OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Luteolin alleviates cognitive impairment in Alzheimer’s disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation
Jiejian Kou, Jun-Zhuo Shi, Yangyang He, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 4, pp. 840-849
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

Anti-Inflammatory and Active Biological Properties of the Plant-Derived Bioactive Compounds Luteolin and Luteolin 7-Glucoside
Sabrina Caporali, Alessandro De Stefano, Cinzia Calabrese, et al.
Nutrients (2022) Vol. 14, Iss. 6, pp. 1155-1155
Open Access | Times Cited: 140

ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Amir Ajoolabady, Dan Lindholm, Jun Ren, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 8
Open Access | Times Cited: 120

Immunopharmacological Activities of Luteolin in Chronic Diseases
Lei Huang, Mi‐Yeon Kim, Jae Youl Cho
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2136-2136
Open Access | Times Cited: 50

Luteolin: A promising multifunctional natural flavonoid for human diseases
Mingtao Zhu, Yanping Sun, Yang Su, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 7, pp. 3417-3443
Open Access | Times Cited: 19

The microbiota–gut–brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
Millicent N. Ekwudo, Carolina Gubert, Anthony J. Hannan
FEBS Journal (2024)
Open Access | Times Cited: 17

Neuroprotective mechanisms of luteolin in glutamate-induced oxidative stress and autophagy-mediated neuronal cell death
Wudtipong Vongthip, Sunita Nilkhet, Kanokkan Boonruang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14

Luteolin for neurodegenerative diseases: a review
Dunuvilla Kavindi Jayawickreme, Cletus Ekwosi, Apurva Anand, et al.
Pharmacological Reports (2024) Vol. 76, Iss. 4, pp. 644-664
Open Access | Times Cited: 13

Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention
Yacoubou Abdoul Razak Mahaman, Kidane Siele Embaye, Huang Fang, et al.
Ageing Research Reviews (2021) Vol. 74, pp. 101544-101544
Closed Access | Times Cited: 97

Recent Updates on Source, Biosynthesis, and Therapeutic Potential of Natural Flavonoid Luteolin: A Review
Nandakumar Muruganathan, Anand Raj Dhanapal, Baskar Venkidasamy, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1145-1145
Open Access | Times Cited: 65

Beneficial effects of natural flavonoids on neuroinflammation
Yu Chen, Fu Peng, Ziwei Xing, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 58

Exploring the Therapeutic Potential of Phytochemicals in Alzheimer’s Disease: Focus on Polyphenols and Monoterpenes
Ilaria Piccialli, Valentina Tedeschi, Lucia Caputo, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38

Luteolin Attenuates Hypertension via Inhibiting NF-κB-Mediated Inflammation and PI3K/Akt Signaling Pathway in the Hypothalamic Paraventricular Nucleus
Hong‐Li Gao, Xiao‐Jing Yu, Yu‐Qi Feng, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 502-502
Open Access | Times Cited: 27

Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway
Pengfei Liu, Yunfeng Zhou, Jun-Zhuo Shi, et al.
Phytomedicine (2023) Vol. 115, pp. 154801-154801
Closed Access | Times Cited: 24

Development of dietary small molecules as multi-targeting treatment strategies for Alzheimer's disease
Rengasamy Balakrishnan, Khoshnur Jannat, Dong‐Kug Choi
Redox Biology (2024) Vol. 71, pp. 103105-103105
Open Access | Times Cited: 10

Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut−brain axis
Yoonsu Kim, Jinkyu Lim, Jisun Oh
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117277-117277
Closed Access | Times Cited: 8

Understanding of Alzheimer's Disease Pathophysiology for Therapeutic Implications of Natural Products as Neuroprotective Agents
Sneh Prabha, Arunabh Choudhury, Asimul Islam, et al.
Ageing Research Reviews (2025), pp. 102680-102680
Closed Access

Discovery of anti-inflammatory natural flavonoids: Diverse scaffolds and promising leads for drug discovery
Junjie Li, Rui Zhao, Peiran Miao, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115791-115791
Closed Access | Times Cited: 20

The protection of luteolin against diabetic cardiomyopathy in rats is related to reversing JNK-suppressed autophagy
Chi Xiao, Mengyuan Chen, Yu-Peng Han, et al.
Food & Function (2023) Vol. 14, Iss. 6, pp. 2740-2749
Closed Access | Times Cited: 15

Luteolin: Nature's promising warrior against Alzheimer's and Parkinson's disease
Ahsas Goyal, Kunal Solanki, Aanchal Verma
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 15

Alzheimer, Parkinson, dementia, and phytochemicals: insight review
Başak CAN, Nevin Şanlıer
Critical Reviews in Food Science and Nutrition (2024), pp. 1-23
Closed Access | Times Cited: 5

Luteolin Alleviates Ulcerative Colitis in Mice by Modulating Gut Microbiota and Plasma Metabolism
Shuai Yang, Hongwei Duan, Zhenxing Yan, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 203-203
Open Access

Antioxidative and Anticancer Potential of Luteolin: A Comprehensive Approach Against Wide Range of Human Malignancies
Mahwish, Muhammad Babar Imran, Hammad Naeem, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 1
Open Access

Lycopene mitigates paclitaxel-induced cognitive impairment in mice; Insights into Nrf2/HO-1, NF-κB/NLRP3, and GRP-78/ATF-6 axes
Nasriah Zakaria, Esther T. Menze, Doaa A. Elsherbiny, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111262-111262
Closed Access

Page 1 - Next Page

Scroll to top